SciELO - Scientific Electronic Library Online

 
vol.86 número4Prevalencia de la deficiencia de hierro en donantes de sangre: Revisión bibliográfica del período 2001-2011Impacto económico del cuidado informal tras la Ley de Promoción de la Autonomía Personal y Atención a las Personas en Situación de Dependencia índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista Española de Salud Pública

versión impresa ISSN 1135-5727

Resumen

CABALLER TARAZONA, Maria et al. A Standardized Amount Indicator by Equivalent Patient to Control Outpatient Pharmaceutical Expenditure, Spain. Rev. Esp. Salud Publica [online]. 2012, vol.86, n.4, pp.371-380. ISSN 1135-5727.

Background: The outpatient pharmaceutical expenditure in developed countries represents a huge percentage of the total health budget, because of that, it is necessary to use tools aimed to control and guarantee an efficient use of these resources. Improving the current construction of the indicator of pharmaceutical expenditure in order to have a more adjusted tool of pharmaceutical expenditure control. Methods: We introduce the concept of "equivalent patient" in the standardization of outpatient pharmaceutical expenditure, considering in its design several socio demographic variables in order to supersede the previous model which just considered the "Co-payment status" for adjusting the outpatient pharmaceutical expenditure. We considered variables as age, sex, co-payment status and nationality to elaborate the concept of equivalent patient. Results: By applying the standardization method we obtained 160 groups of consumption with weights from 0,10 to 4,39 equivalent patients. Conclusions: We obtained a tool capable of improving the construction of Pharmaceutical Expenditure Indicators, which are essential for the design of measures aimed to stimulate the rational use of drugs. In a micro level of analysis, the new indicator is useful to establish economic incentives aimed to encourage good performance from physicians in the prescription field.

Palabras clave : Prescribing; Assessment methodology; Pharmaceutical costs; Spain.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons